Back to CAPTRUST FINANCIAL ADVISORS CAPTRUST FINANCIAL ADVISORS

NGENNGEN
Showing 2 of 6 quarters

Position history for CAPTRUST FINANCIAL ADVISORSCAPTRUST FINANCIAL ADVISORS's holdings in NERVGEN PHARMA CORP

CAPTRUST FINANCIAL ADVISORS holds 64,423 shares of NGEN (NERVGEN PHARMA CORP), worth $132,711 as of 2026-Q2. The position was increased (+3.3% shares). NGEN represents 0.0% of CAPTRUST FINANCIAL ADVISORS's portfolio.

Current Value

$132,711

Current Shares

64,423

Total Value Change

-$102,413

Total Shares Change

+2,056

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
64,423
+3.3%
$132,7110.0%$2.06
23
2026-Q1
New
62,367
-
$235,1240.0%$3.95
32

Other major holders of NGEN: LMR Partners LLP, MARSHALL WACE, LLP, UBS Group AG, BANK OF AMERICA CORP /DE/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used